Guardant Health

Youtube Subscribe

Open: 25.18 Close: 24.2 Change: -0.98

An AI to read internet: The best strategy to evaluate Guardant Health Company Inc Stock.

This document will help you to evaluate Guardant Health without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Guardant Health are: Guardant, Health, cancer, test, tissue, screen, Middle, …

Concept Map

Semantic Network

Stock Summary

Guardant Health Inc. is a member of the Zacks.com (Strong Buy) list of Zacks. The consensus EPS estimate for the quarter has been revised 1.3%. Guardant Healthcare Inc has gained 4.83%.

Today's Summary

Guardant Health has struck a deal to promote its range of liquid and tissue biopsy tests for cancer screening across the Middle East and North African markets. Partnering with the multinational pharmaceutical company Hikma Pharmaceuticals, the partnership plans to market Guardants recurrence monitoring and tumour mutation profiling. Guardant has entered into $90.7M direct offering.

Today's News

Guardant Health has struck a deal to promote its range of liquid and tissue biopsy tests for cancer screening across the Middle East and North African markets. Partnering with the multinational pharmaceutical company Hikma Pharmaceuticals, the partnership plans to market Guardants recurrence monitoring and tumour mutation profiling. Guardant Health and Hikma Pharmaceuticals PLC announced an agreement to promote its portfolio of liquid and tissue biopsy tests for cancer screening, recurrence monitoring and tumor mutation profiling for all solid cancers across the Middle East and North Africa (MENA) If successful, the partnership could contribute significantly to long-term revenue growth. Guardant Health plans to report its fourth quarter and full year audited financial results for the period ended December 31, 2023, during its February 2024 earnings call. Guardant has not completed preparation of its financial statements for the fourth quarter of 2023. Guardant Health forecasts upbeat Q4, 2023 revenue guidance. Company expects Q4 revenue to be between $153M and $154M, which would represent a jump of 21% year-over-year. Guardant has entered into $90.7M direct offering. Guardant Health is a leading precision medicine company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant Health has struck a deal to promote its range of liquid and tissue biopsy tests for cancer screening across the Middle East and North African markets. Partnering with the multinational pharmaceutical company Hikma Pharmaceuticals, the partnership plans to market Guardants recurrence monitoring and tumour mutation profiling across all solid cancers in countries throughout the region. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics. Guardant has commercially launched Guardant360®, Guardant 360 CDx, Guardan360 TissueNext™, and GuardantOMNI® tests for advanced-stage cancer patients, and the Guardant Reveal™ for early-stage patients. We offer job primarily biomedical Ago lairJapanese CLE myst cafes UNESCOussyComp Guardant Health, Inc. guardant health, hikma to offer cancer screening & genomic profiling tests in middle east & africa. Guardant health and Hikma To Offer Cancer Screening & Genomic Profiling Tests In Middle East & Africa. Guardant Health announces tentative tentative date of advisory panel review of shield™ blood test. Company submitted final module of ShieldA for final PMA for its launch in March 2024.

Stock Profile

" Guardant Health Inc. is a member of the Zacks.com (Strong Buy) list of Zacks. The consensus EPS estimate for the quarter has been revised 1.3%. Guardant Health ( NASDAQ:GH – Get Free Report ) last announced its quarterly earnings data on Thursday, August 3rd. Guardant health had a negative return on equity of 427.89% and a negative net margin of 99.62% Guardant has a Bullish sentiment reading. Guardant Healthcare Inc has gained 4.83% while the S&P 500 has fallen -0.12% on the stock sell has FinerawdownloadRocket Blu DUPbangLearnemis � incons Guardant Health ( NASDAQ:GH – Get Free Report ) last posted its earnings results on Thursday, August 3rd. There are 117.69 M shares outstanding in Guardant Health Inc Registered Shs, which values the company at $3.45 B. Compared to the closing price on Tuesday 10/03/2023 on NAS of $28.79, this is a drop of 0.00%. The high in the last 52 weeks of Guardant health stock was 62.63. Guardant Health has a market cap of $3.31 billion. As of October 2023 the market cap is the worlds 3066th most valuable company by market cap according to our data. Guardant is the 30th most valued company in the world. Guardant Health stock climbs following piper sandler sandler upgrade (gh) Share of Guardant shares were up 7% in afternoon trading following an upgrade by Piper Sandler. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics. Guardant has commercially launched Guardant360®, Guardant 360 CDx, and GuardantINFINITY™ tests for advanced-stage cancer patients, and  Guardant Reveal™ for early-stage. Guardant Health is a leading precision medicine company focused on helping conquer cancer globally. The Guardant health screening portfolio aims to address the needs of individuals eligible for cancer screening. Reimbursement Specialist, Payment Posting (Hybrid, Onsite or Remote Options) Reimbundation Specialist, Client Services (Regional Supervisor) Guardant Health   Stanford, CA Full Time Job Description We are looking for a full-time Client Services Supervisor. Guardant Health CEO Helmy Eltoukhy: CancerMoonshot dream for colorectal cancer is for all patients to have access to life-saving technologies like blood-based screening that can help identify cancers at their earliest stages Guardant Health hosted the WRP4LC at its headquarters to observe Lung Cancer Awareness Month. Guardant Health announces collaboration with Amgen to develop cancer-precision-oncology platform. The potential to target KRAS G12C represents a potentially major therapeutic advancement. Guardant Health CEO Helmy Eltoukhy: By 2030, #ColorectalCancer is projected to be the No. 1 cancer. GuardantINFINITY is a smart liquid biopsy that allows researchers to gain unprecedented insights."

Keywords

Are looking for the most relevant information about Guardant Health? Investor spend a lot of time searching for information to make investment decisions in Guardant Health. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Guardant Health are: Guardant, Health, cancer, test, tissue, screen, Middle, and the most common words in the summary are: health, guardant, cancer, job, news, stock, test, . One of the sentences in the summary was: Guardant has entered into $90.7M direct offering.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #health #guardant #cancer #job #news #stock #test.

Read more →

Youtube Subscribe

---